The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of copanlisib (BAY 80-6946) in combination with gemcitabine and cisplatin in advanced cholangiocarcinoma.
 
Rutika Jitesh Mehta
No Relationships to Disclose
 
Dae Won Kim
No Relationships to Disclose
 
Heloisa P. Soares
Consulting or Advisory Role - Cornerstone Pharmaceuticals; Ipsen
Speakers' Bureau - Celgene; Novartis
 
Jongphil Kim
No Relationships to Disclose
 
Richard D. Kim
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Lilly
Speakers' Bureau - Lilly; Taiho Pharmaceutical
Research Funding - Bayer; Eisai; Novartis